Duplex realtime PCR method for Epstein–Barr virus and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection

Duplex realtime PCR method for Epstein–Barr virus and human DNA quantification: its application for post-transplant lymphoproliferative disorders detection

Introduction: The quantification of circulating Epstein–Barr virus (EBV) DNA is used to monitor transplant patients as an early marker of Post-Transplant Lymphoproliferative Disorders (PTLD). So far no standardized methodology exists for such determination. Objective: Our purpose was to develop and...

Full description

Bibliographic Details
Main Authors:	María Dolores Fellner, Karina Durand, Marcelo Rodriguez, Lucía Irazu, Virginia Alonio, María Alejandra Picconi
Format:	Article
Language:	English
Published:	Elsevier 2014-05-01
Series:	Brazilian Journal of Infectious Diseases
Online Access:	http://www.sciencedirect.com/science/article/pii/S141386701300281X

Similar Items

Epstein-Barr virus-associated lymphoproliferative disorders
by: Ewelina Grywalska, et al.
Published: (2013-05-01)

Automated quantification of Epstein-Barr virus in whole blood for post-transplant lymphoproliferative disorders monitoring
by: Maud Salmona, et al.
Published: (2020-02-01)

Epstein-Barr Virus-Associated T and NK-Cell Lymphoproliferative Diseases
by: Wook Youn Kim, et al.
Published: (2019-03-01)

Epstein-Barr virus in the pathogenesis of post-transpant lymphoproliferative disease
by: Burns, David Meriton
Published: (2015)

Epstein-Barr Virus-associated T/NK-cell Lymphoproliferative Diseases
Published: (2019)

Epstein-Barr virus induced hemophagocytic lymphohistiocytosis in X-linked lymphoproliferative disease
by: Senthilkumar Sankararaman, et al.
Published: (2014-04-01)

Advances in Understanding the Pathogenesis of Epstein-Barr Virus-Associated Lymphoproliferative Disorders
by: Xi Yang, et al.
Published: (2015-10-01)

Case of primary intraocular lymphoproliferative disorder caused by Epstein–Barr Virus
by: Yumiko Ban, et al.
Published: (2020-07-01)

Editorial: Epstein-Barr Virus-Associated T/NK-Cell Lymphoproliferative Diseases
by: Shigeyoshi Fujiwara, et al.
Published: (2019-07-01)

Transcriptomic Abnormalities in Epstein Barr Virus Associated T/NK Lymphoproliferative Disorders
by: Sanjay de Mel, et al.
Published: (2019-01-01)

Molecular signature of Epstein Barr virus-positive Burkitt lymphoma and post transplant lymphoproliferative disorder suggest different roles for Epstein Barr virus
by: Mohsen eNavari, et al.
Published: (2014-12-01)

Epstein-Barr Virus Positive B-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract
by: Eri Ishikawa, et al.
Published: (2021-07-01)

Epstein Barr Virus Associated B-Cell Lymphomas and Iatrogenic Lymphoproliferative Disorders
by: Jennifer L. Crombie, et al.
Published: (2019-03-01)

Epstein-Barr Virus-Positive T/NK-Cell Lymphoproliferative Diseases in Chinese Mainland
by: Junhong Ai, et al.
Published: (2018-10-01)

Inherited Immunodeficiencies With High Predisposition to Epstein–Barr Virus-Driven Lymphoproliferative Diseases
by: Sylvain Latour, et al.
Published: (2018-06-01)

Epstein-Barr virus-positive T/NK-cell lymphoproliferative diseases in children and adolescents
by: Young-Hyeh Ko
Published: (2018-03-01)

Adoptive immunotherapy for Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease
by: Johannessen, Ingólfur
Published: (2007)

Epstein-Barr Virus–Associated Lymphoproliferative Disorders: Review and Update on 2016 WHO Classification
by: Hyun-Jung Kim, et al.
Published: (2017-07-01)

Cytologic Analysis of Epstein-Barr Virus-Associated T/Natural Killer-Cell Lymphoproliferative Diseases
by: Akihiro Yachie
Published: (2018-11-01)

Chronic Epstein-Barr virus infection causing both benign and malignant lymphoproliferative disorders
by: Yoojin Kwun, et al.
Published: (2014-09-01)

Posttransplant Lymphoproliferative Disorders : Studies of Epstein-Barr Virus, Regulatory T Cells and Tumor Origin
by: Kinch, Amelie
Published: (2014)

Identifying and Targeting Immune Escape Mechanisms in Epstein-Barr Virus-Driven Lymphoproliferative Disease
by: Patton, John Thomas, Jr.
Published: (2016)

CD30-Positive T-Cell Lymphoproliferative Disease of the Oral Mucosa in Children: A Manifestation of Epstein-Barr Virus-Associated T-Lymphoproliferative Disorder
by: Mineui Hong, et al.
Published: (2015-11-01)

Opportunities to Target the Life Cycle of Epstein-Barr Virus (EBV) in EBV-Associated Lymphoproliferative Disorders
by: James P. Dugan, et al.
Published: (2019-03-01)

A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
by: Midori Ando, et al.
Published: (2013-01-01)

Neopterin and Endogenous Interferon Gamma in Serum of Patients with Epstein-Barr Virus-associated Lymphoproliferative Diseases
by: Schuster Volker, et al.
Published: (1990-09-01)

Epstein-Barr virus associated post-transplant lymphoproliferative disorders: preventative measures and current treatments
by: De Leon, Sherryl A.
Published: (2015)

Epstein-Barr virus induced post-transplant lymphoproliferative disorder presenting with unilateral retinal involvement
by: Mainguy Adam, et al.
Published: (2021-09-01)

Identifying Risk Profiles and Generating Protective Vaccine for Epstein-Barr Virus-Associated Lymphoproliferative Diseases
by: Ahmed, Elshafa Hassan
Published: (2018)

Clinicopathological findings of systemic Epstein-Barr virus-positive T-lymphoproliferative diseases in younger and older adults
by: Ziyao Wang, et al.
Published: (2021-06-01)

Detección del Virus de Epstein-Barr en linfoma mediante qPCR //Detection of Epstein-Barr Virus (EBV) in lymphoma through qPCR
by: Sunny Sánchez-Giler, et al.
Published: (2018-06-01)

Biological Difference Between Epstein–Barr Virus Positive and Negative Post-transplant Lymphoproliferative Disorders and Their Clinical Impact
by: Valeria Ferla, et al.
Published: (2020-05-01)

Epstein–Barr Virus-Associated T- and NK-Cell Lymphoproliferative Diseases: A Review of Clinical and Pathological Features
by: Charlotte Syrykh, et al.
Published: (2021-07-01)

Novel ZAP-70-Related Immunodeficiency Presenting with Epstein–Barr Virus Lymphoproliferative Disorder and Hemophagocytic Lymphohistiocytosis
by: Moriah Forster, et al.
Published: (2021-01-01)

Endobronchial Epstein-Barr Virus Associated Post-transplant Lymphoproliferative Disorder in Hematopoietic Stem Cell Transplantation
by: S. Feuillet, et al.
Published: (2009-01-01)

Post-transplant lymphoproliferative disorders and Epstein-Barr virus DNAemia in a cohort of lung transplant recipients
by: Tinelli Carmine, et al.
Published: (2011-09-01)

Pathologic study of childhood lymphoproliferative disorders in Taiwan:with a special reference to the association with Epstein-Barr virus
by: LI,SHENG-HUANG, et al.
Published: (1990)

The Role of T Lymphocytes in the hu-PBMC-SCID Mouse Model of Epstein-Barr Virus-Associated Lymphoproliferative Disease
by: Cromwell, Mary A.
Published: (1995)

Epstein-Barr Virus-Related B Cell Lymphoproliferative Disorder After Hematopoietic Stem Cell Transplantation
by: Chiereghin, Angela <1982>
Published: (2016)

Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative disease
by: Paibel Aguayo-Hiraldo, et al.
Published: (2016-01-01)